WoundSource Page Designs_White Papers small

A Closer Look at the Use of Placental Membranes for Wound Closure

GRAFIX-White Paper-Final
 
By submitting your information through this form, you confirm that you agree to WoundSource's Privacy Policy , as well as sharing your information with any partners for marketing purposes. You can opt out at any time.
 

Debilitating chronic wounds, including diabetic foot ulcers and venous ulcers, affect millions of patients in the United States every year. A growing body of research shows that treatment-refractory chronic wounds may respond well to the use of placental tissues.

This guide, sponsored by Smith+Nephew, makers of GRAFIX Membrane and STRAVIX Tissue, discusses the challenges of chronic wound care and the encouraging results observed with placental tissue products in the treatment of these difficult wounds. The guide also provides case studies of successful GRAFIX Membrane and STRAVIX Tissue use in patients with foot ulcers and infections, as well as post-surgical tendon rupture.

Wound care professionals will be interested in these advanced wound care products, which have shown promising results in the treatment of hard-to-heal chronic wounds.

This white paper contains information on the following topics:

Epidemiology of chronic wounds
TIME principles of wound bed preparation
Rationale for placental tissue use in chronic wound care
Properties and effectiveness of GRAFIX Membrane products
STRAVIX Tissue in chronic wound care
Case studies of GRAFIX Membrane and STRAVIX Tissue use

This paper is written for wound care clinicians and purchasing directors with an interest in product solutions. This paper was developed by an independent third party.

Sponsored by Smith+Nephew, Inc.

Debilitating chronic wounds, including diabetic foot ulcers and venous ulcers, affect millions of patients in the United States every year. A growing body of research shows that treatment-refractory chronic wounds may respond well to the use of placental tissues.

This guide, sponsored by Smith+Nephew, makers of GRAFIX and STRAVIX, discusses the challenges of chronic wound care and the encouraging results observed with placental tissue products in the treatment of these difficult wounds. The guide also provides case studies of successful GRAFIX and STRAVIX use in patients with foot ulcers and infections, as well as post-surgical tendon rupture.

Wound care professionals will be interested in these advanced wound care products, which have shown promising results in the treatment of hard-to-heal chronic wounds.

This white paper contains information on the following topics:

Epidemiology of chronic wounds
TIME principles of wound bed preparation
Rationale for placental tissue use in chronic wound care
Properties and effectiveness of GRAFIX products
STRAVIX in chronic wound care
Case studies of GRAFIX and STRAVIX use

This paper is written for wound care clinicians and purchasing directors with an interest in product solutions. This paper was developed by an independent third party.

Sponsored by Smith+Nephew, Inc.

WoundSource
The World’s Definitive Source for Wound Care & Product Information